These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 19417722)
21. Essential arterial hypertension and stone disease. Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288 [TBL] [Abstract][Full Text] [Related]
22. Seasonal variations in urinary risk factors among patients with nephrolithiasis. Stuart RO 2nd ; Hill K; Poindexter J; Pak CY J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932 [TBL] [Abstract][Full Text] [Related]
23. Effect of diclofenac-Na on 24-hour urinary excretion of creatinine, calcium, uric acid and glycosaminoglycans in adult patients with recurrent calcium oxalate nephrolithiasis. Hemal AK; Sidhu H; Thind SK; Nath R; Vaidyanathan S Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):44-6. PubMed ID: 2744906 [TBL] [Abstract][Full Text] [Related]
24. Dyslipidemia and kidney stone risk. Torricelli FC; De SK; Gebreselassie S; Li I; Sarkissian C; Monga M J Urol; 2014 Mar; 191(3):667-72. PubMed ID: 24055417 [TBL] [Abstract][Full Text] [Related]
25. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Taylor EN; Mount DB; Forman JP; Curhan GC Am J Kidney Dis; 2006 May; 47(5):780-9. PubMed ID: 16632016 [TBL] [Abstract][Full Text] [Related]
26. Metabolic investigation in patients with nephrolithiasis. Santos FMD; Peres AK; Mandotti MR; Peres LAB Einstein (Sao Paulo); 2017; 15(4):452-456. PubMed ID: 29267427 [TBL] [Abstract][Full Text] [Related]
27. Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus. Hartman C; Friedlander JI; Moreira DM; Elsamra SE; Smith AD; Okeke Z BJU Int; 2015 Apr; 115(4):619-24. PubMed ID: 24823472 [TBL] [Abstract][Full Text] [Related]
28. [Relation between diet protein and calciuria in children and adolescents with nephrolitiasis]. de Andrade AS; de Silva AM; Jalles LM; Lopes MF; de Brito TN; de Pedrosa LF Acta Cir Bras; 2005; 20 Suppl 1():242-6. PubMed ID: 17768814 [TBL] [Abstract][Full Text] [Related]
29. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731 [TBL] [Abstract][Full Text] [Related]
30. Association of thin basement membrane nephropathy with hypercalciuria, hyperuricosuria and nephrolithiasis. Praga M; Martínez MA; Andrés A; Alegre R; Vara J; Morales E; Herrero JC; Novo O; Rodicio JL Kidney Int; 1998 Sep; 54(3):915-20. PubMed ID: 9734616 [TBL] [Abstract][Full Text] [Related]
32. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467 [TBL] [Abstract][Full Text] [Related]
33. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Worcester EM; Gillen DL; Evan AP; Parks JH; Wright K; Trumbore L; Nakagawa Y; Coe FL Am J Physiol Renal Physiol; 2007 Jan; 292(1):F66-75. PubMed ID: 17210796 [TBL] [Abstract][Full Text] [Related]